Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 3116Neoplasms 2459Carcinoma, Non-Small-Cell Lung 1858Prostatic Neoplasms 1623Colorectal Neoplasms 1401Lung Neoplasms 1293Multiple Myeloma 930Neoplasm Metastasis 919Leukemia, Myeloid, Acute 879Pancreatic Neoplasms 853Ovarian Neoplasms 800Melanoma 782Carcinoma, Hepatocellular 733Stomach Neoplasms 647Squamous Cell Carcinoma of Head and Neck 635Recurrence 635Brain Neoplasms 624Head and Neck Neoplasms 598Glioblastoma 558Lymphoma 549Uterine Cervical Neoplasms 535Triple Negative Breast Neoplasms 511Precursor Cell Lymphoblastic Leukemia-Lymphoma 509Carcinoma, Renal Cell 501Hematologic Neoplasms 464Urinary Bladder Neoplasms 460Endometrial Neoplasms 457Colonic Neoplasms 445Sarcoma 433Lymphoma, Non-Hodgkin 432

Interventions

enzalutamide 1Radiosurgery 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Advanced Prostate Cancer × 1 year × Clear all
NCT06369246 2026-03-09

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

M.D. Anderson Cancer Center

Phase 1 Recruiting
70 enrolled
Genitourinary

Advanced Prostate Cancer

NCT03938649 2026-03-04

SRAM study_Postate Cancer

Chinese University of Hong Kong

Phase 2 Active not recruiting
120 enrolled
Genitourinary

Advanced Prostate Cancer

NCT06335914 2026-02-12

Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer

University Health Network, Toronto

Phase NA Recruiting
30 enrolled
Genitourinary

Advanced Prostate Cancer

NCT07115446 2025-12-05

Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer

Hansoh BioMedical R&D Company

Phase 1 Recruiting
63 enrolled
Genitourinary

Advanced Prostate Cancer

NCT07198633 2025-09-30

A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer

Qilu Pharmaceutical Co., Ltd.

Phase 1/2 Not yet recruiting
212 enrolled
Genitourinary

Advanced Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡